Research and Development

Showing 15 posts of 9594 posts found.

drrrr

White House announces Dr Moncef Slaoui, the former head of GSK’s vaccine division, as the co-leader of Operation Warp Speed

May 18, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

President Donald Trump has announced that Dr Moncef Slaoui, the former head of GlaxoSmithKline’s vaccine division, will head up Operation …
aviv_regev

Genentech’s retiring R&D head to be replaced by MIT executive

May 15, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, Roche, appointment

Michael Varney, industry veteran and Head of Research & Development at Genentech, has announced he is to leave the role …
debs

Debra Feldman announced as Vice President, Head of Regulatory at Dyne Therapeutics

May 15, 2020 Research and Development

Dyne Therapeutics has announced the appointment of Debra Feldman as their new Vice President, Head of Regulatory. Feldman said on …

Abbott’s COVID-19 test, used at the White House, fails to identify up to 48% of positive cases, study argues

May 15, 2020 Medical Communications, Research and Development Abbott, COVID-19, coronavirus, pharma

Abbott’s 13-minute ID NOW COVID-19 testing kits have come under scrutiny after a study from New York University (NYU) revealed …
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

May 15, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10

The news this week continues to be dominated by COVID-19 vaccines and treatments, with the NIAID announcing the launch of …
janssen_latest_logo_on_sign_closer

100% of multiple myeloma patients respond to Janssen’s investigational CAR T therapy, data shows

May 14, 2020 Research and Development CAR T, CAR-T, Janssen, multiple myeloma, pharma

Janssen has revealed new Phase1b/2 findings of the efficacy of its investigational B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T cell …
fda

FDA grants Fast Track designation for Moderna’s coronavirus vaccine candidate

May 13, 2020 Research and Development COVID-19, coronavirs

The FDA has granted Fast Track designation for Moderna Inc’s mRNA vaccine candidate against the coronavirus. The regulatory body had …
researcherssss

AMAG Pharmaceuticals to cut 30% of staff as part of restructure

May 13, 2020 Research and Development COVID-19, coronavirus

AMAG Pharmaceuticals announced that it will cut 30% of its staff, or 140 jobs, as part of a companywide restructuring. …
generics

Gilead signs deal with generic drugmakers to expand global supply of remdesivir

May 13, 2020 Research and Development COVID-19, coronavirus, remdesivir

Gilead Sciences has signed an exclusive licensing agreement with five generics drug companies in India and Pakistan to supply them …
coroanrvisu_cdc

Pharmafile.com’s weekly COVID-19 news round-up

May 13, 2020 Research and Development COVID-19, coronavirus

Developments in treatments for COVID-19 continue to dominate the news as the latest in hydroxychloroquine trials shows it does not …
trialsssssss

Researchers in Denmark testing if senicapoc drug can reduce lung damage in COVID-19 patients

May 13, 2020 Research and Development COVID-19, Sars, coronavirus

Scientists are studying if senicapoc, a treatment for sickle cell anemia, can be repurposed to mitigate damage to a COVID-19 …
korea_govt

South Korea says Ebola drug remdesivir may not be suitable for all coronavirus patients

May 6, 2020 Research and Development COVID-19, coronavirus, south korea

South Korea says that remdesivir, traditionally used in treating Ebola, may not be effective enough in treating COVID-19 patients. South …
fda2outsideweb

AZ’s Farxiga becomes first FDA-approved SGLT2 inhibitor for heart failure with reduced ejection fraction

May 6, 2020 Research and Development, Sales and Marketing AstraZeneca, FDA, farxiga, heart failure

The FDA has moved to approve an oral tablet formulation of AstraZeneca’s Farxiga (dapagliflozin) to reduce the risk of cardiovascular …
partnership

Portola Pharmaceuticals to merge with Alexion in $1.41bn cash deal

May 6, 2020 Research and Development, Sales and Marketing Alexion, Portola Pharmaceuticals, pharma

Alexion has announced it is to acquire Boston-based blood disorder specialist Portola Pharmaceuticals in a transaction to the value of …
The Gateway to Local Adoption Series

Latest content